Inclusion completed

Trabectedin for recurrent grade II or III meningioma: a randomized phase II study of the EORTC Brain Tumor Group

Cancer type: Meningioma

Phase: II

Principal Investigator: Brandal Petter

Country: NO

Keywords: Norway, Oslo, Trabectedin, Meningioma

Status: Inclusion completed

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02234050?term=EORTC1320&rank=1